Jodi Devlin, Chief of Clinical Operations at TriSalus Life Sciences ($TLSI), made one open market sale of company shares in the last year, totaling $24,678. Her most recent TLSI insider sale occurred on May 19, 2025. This activity ranks her 10,930th among 11,678 insiders with sales, well below the average of $8.6 million per person across 6.4 transactions. She recorded no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 12, 2026 | TriSalus Life Sciences, Inc. | $TLSI | Devlin Jodi | Chief of Clinical Operations | S | Common Stock | 1772 | $4.09 | 97,637.0000 | 49,964,311 | 1.78% | 0.00% |
| March 11, 2026 | TriSalus Life Sciences, Inc. | $TLSI | Devlin Jodi | Chief of Clinical Operations | S | Common Stock | 1162 | $4.13 | 99,409.0000 | 49,964,311 | 1.16% | 0.00% |
| March 16, 2026 | TriSalus Life Sciences, Inc. | $TLSI | Devlin Jodi | Chief of Clinical Operations | S | Common Stock | 273 | $4.12 | 97,364.0000 | 49,964,311 | 0.28% | 0.00% |
| Nov. 24, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Devlin Jodi | Chief of Clinical Operations | A | Employee Stock Option (right to buy) | 100000 | $0.00 | 463,750.0000 | 49,964,311 | 27.49% | 0.20% |
| Nov. 24, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Devlin Jodi | Chief of Clinical Operations | A | Common Stock | 50000 | $0.00 | 100,571.0000 | 49,964,311 | 98.87% | 0.10% |
| May 19, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Devlin Jodi | Chief of Clinical Operations | A | Common Stock | 24131 | $5.18 | 57,528.0000 | 32,272,462 | 72.25% | 0.07% |
| May 19, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Devlin Jodi | Chief of Clinical Operations | S | Common Stock | 4764 | $5.18 | 52,764.0000 | 32,272,462 | 8.28% | 0.01% |
| Feb. 18, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Devlin Jodi | Chief of Clinical Operations | A | Common Stock | 5272 | $0.00 | 33,397.0000 | 0 | 18.74% | 0.00% |
| Jan. 27, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Devlin Jodi | Chief of COMMERC. OPERATIONS | A | Employee Stock Option (right to buy) | 63750 | $0.00 | 63,750.0000 | 0 | 9999.99% | 0.00% |
| Jan. 27, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Devlin Jodi | Chief of COMMERC. OPERATIONS | A | Common Stock | 10625 | $0.00 | 28,125.0000 | 0 | 60.71% | 0.00% |
| Feb. 12, 2024 | TriSalus Life Sciences, Inc. | $TLSI | Devlin Jodi | PRESIDENT, COMMERC. OPERATIONS | A | Employee Stock Option (right to buy) | 105000 | $0.00 | 105,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 12, 2024 | TriSalus Life Sciences, Inc. | $TLSI | Devlin Jodi | PRESIDENT, COMMERC. OPERATIONS | A | Common Stock | 17500 | $0.00 | 17,500.0000 | 0 | 9999.99% | 0.00% |